celiprolol has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Boutouyrie, P; Denarié, N; Dumez, Y; Fiessinger, JN; Gimenez-Roqueplo, AP; Jeunemaitre, X; Julia, P; Khau Van Kien, P; Lahlou-Laforêt, K; Mousseaux, E; Perdu, J; Sapoval, M; Touraine, P; Trystram, D; Vignal-Clermont, C; Zinzindohoué, F | 1 |
1 review(s) available for celiprolol and ascorbic acid
| Article | Year |
|---|---|
[Vascular Ehlers-Danlos syndrome].
Topics: Adult; Ascorbic Acid; Celiprolol; Child; Clinical Trials as Topic; Collagen Type III; Contraception; Ehlers-Danlos Syndrome; Female; Genetic Counseling; Humans; Male; Mutation; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Tomography, X-Ray Computed; Ultrasonography, Doppler; Vasodilator Agents | 2006 |
1 other study(ies) available for celiprolol and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |